Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Cash & Current Investments (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) recorded Cash & Current Investments of $31.1 million in Q3 2026, down 68.6% from $99.1 million a year earlier but up 2.3% from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Cash & Current Investments (2019 - 2026) Analysis & Trends

At the end of FY2025, Aligos Therapeutics reported Cash & Current Investments of $77.8 million, up 36.7% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -20.4% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $56.9 million in FY2024 (-58.1%), $135.7 million in FY2023 (+7.9%), $125.8 million in FY2022 (-38.9%) and $205.8 million in FY2021 (-15.5%).
  • Quarterly Cash & Current Investments has ranged from $30.4 million in Q2 2026 to $205.8 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has declined for three consecutive quarters, with an average decline of 17.6% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 36.7% in Q4 2025, against a decline of 75.3% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $30.4 million (Q2 2026), $54.9 million (Q1 2026) and $77.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.23 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 10.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 505.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 14.27 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - 31.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 31.10 Mn
Jun 30, 2026 30.40 Mn
Mar 31, 2026 54.90 Mn
Dec 31, 2025 77.80 Mn
Sep 30, 2025 99.10 Mn
Jun 30, 2025 122.90 Mn
Mar 31, 2025 137.90 Mn
Dec 31, 2024 56.90 Mn
Sep 30, 2024 74.90 Mn
Jun 30, 2024 94.50 Mn
Mar 31, 2024 112.70 Mn
Dec 31, 2023 135.70 Mn
Sep 30, 2023 70.40 Mn
Jun 30, 2023 90.80 Mn
Mar 31, 2023 103.50 Mn
Dec 31, 2022 125.80 Mn
Sep 30, 2022 142.30 Mn
Jun 30, 2022 159.30 Mn
Mar 31, 2022 183.20 Mn
Dec 31, 2021 205.80 Mn
API Access

Aligos Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ALGS&period=max&api_key=YOUR_API_KEY